← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV18행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyPhase 2
Lovastatin (Lovastatin)
Washington University School of Me…·Clinical Stage IV HPV-Mediated (p1…
32 trials
Overview
Program
Lovastatin
Overview
Company
Washington University School of Medicine
Overview
Modality
ANTIBODY
Overview
Target
Clinical Stage IV HPV-Mediated (p16-Posi
Overview
Indication
Breast Cancer; Advanced Breast Cancer
Overview
Phase
PHASE_2
Overview
Status
RECRUITING
MoA
Mechanism
targeting α7-nACh receptor
MoA
Biomarker
biomarker in AML and reveals that lovastatin triggers apoptosis by inhibiting ER stress, providing a mechanis
PK/PD
Species
Rat, ration assays, in vivo xenograft
PK/PD
Animal (cat.)
Rat, In vitro
PK/PD
Experiment
PK
Toxicology
Species
Rat, ration assays, in vivo xenograft
Toxicology
Animal (cat.)
Rat, In vitro
Toxicology
Major finding
Clinical outcomes of ferroptosis-inducing agents in glioblastoma: A systematic review of clinical trials.. Glioblastoma (GBM) is the most aggressive type of primary central nervous system tumor with poor prognosis. Despite multimodal therapy, GBM remains clinically challenging, necessitating exploration of novel therapeutic strategies. Ferroptosis, an iron-dependent regulated cell death, has emerg…
Clinical
Data Tier / Score
A · 32
Clinical
Program phase
PHASE_2
Clinical
Clinical sync
2026년 7월 13일 (1일 전)